JoseMEstebanMDPhD(He/Him)

PubMed

• 78 citations
  New Method for the Chelation of Indium-111 to Monoclonal Antibodies: Biodistribution and Imaging of Athymic Mice Bearing Human Colon Carcinoma Xenografts
  Jose M. Esteban, Jeffrey Schlom, Otto A. Gansow, Robert W. Atcher, Martin W. Brechbiel
  Journal of Nuclear Medicine. 1987-05-01
• 32 citations
  Effects of various fixatives and fixation conditions on DNA ploidy analysis. A need for strict internal DNA standards.
  Jose M. Esteban, Khalil Sheibani, Margaret Owens, John P. Joyce, Ann Bailey
  American Journal of Clinical Pathology. 1991-04-01
• 425 citations
  Measurement of gene expression in archival paraffin-embedded tissues: development and performance of a 92-gene reverse transcriptase-polymerase chain reaction assay.
  Maureen T. Cronin, Mylan Pho, Debjani Dutta, James C. Stephans, Steven Shak
  The American Journal of Pathology. 2004-01-01

Journal Articles

• Whole Transcriptome RNA-Seq Analysis of Breast Cancer Recurrence Risk Using Formalin-Fixed Paraffin-Embedded Tumor Tissue.  
  78. Dominick Sinicropi; Kunbin Qu; Francois Collin; Michael Crager; Mei-Lan Liu; Robert Pelham; Mylan Pho; Andrew Dei Rossi; Jennie Jeong; Aaron Scott; Ranjana Ambanna..., PLoS ONE, 1/1/2012
• Inflammatory Myofibroblastic Tumors of the UrinaryTract: A Clinicopathological Study of 46 Cases, Including a Malignant Example and a Subset Associated with High Grade...  
  Montgomery E, Shuster DD, Burkart A, Esteban JM, Sgrignoli A, Elwood L,Vaughn DJ, Griffin CA, Epstein JI, Am J Surg Pathol, 1/1/2006
• Measurement of Gene Expression in Archival Paraffin-embedded Tissues: Development and Performance of a 92 Gene RT-PCR Assay.  
  M Cronin, M Pho, D Dutta, J Stephans, S Shak, MKiefer, Jose M. Esteban, and J Baker, Amer. Jour. Pathol., 1/1/2004
• Benign metastasizing leiomyoma of the uterus.  
  Esteban JM, Allen WM, and Schaerf RH, Arch Pathol Lab Med, 1/1/1999
• Shared tumor antigens in colorectal carcinoma, carcinoid and neuroendocrine tumors.  
  Tobi M, Darmon E, Rozen P, Baratz M, Lundqvist M, Oberg K, Thomas P, Esteban JM, Hefta S, Paxton R, Shively J, Cancer Detection and Prevention, 1/1/1998
• Dose escalation of 111-indium labeled anti-carcinoembryonic antigen chimeric monoclonal antibody (chimeric T84.66) in presurgical colo-rectal cancer patients.  
  Wong JYC, Chu DCJ, Yamauchi D, Odom-Myrion TL, Williams LE, Liu A. Esteban JM, Wu AM, Primus FJ, Beatty JD, Wilson LA, Shively JE, Raubitschek A, J. of Nuclear Medicine, 1/1/1998
• Computer-assisted image analysis of vascularity.  
  Simpson JF, Battifora H, Esteban JM and Ahn C., Am J Clin Pathol, 1/1/1997
• Computer-assisted image analysis of vascularity (Editorial-Letter).  
  Simpson JF, Ahn C, Esteban JM, Battifora H, Am J Clin Pathol, 1/1/1997
• Clinical evaluation of an 111In labeled anti-CEA chimeric monoclonal antibody (cT84.66) in phase I radioimmuntherapy trial.  
  Wong JYC, Thomas GE, Yamauchi DM, Williams, LE Odom-Mayron T, Esteban JM, Neumaier M, Wu AM, Primus FJ, Shively JE, Raubitschek AA, J Nucl Med, 1/1/1997
• Aneuploidy of Mammary Intraductal Carcinomas Detected On Tissue Sections By Non-Fluorescent In Situ Hybridization.  
  Esteban JM, Jenkins S, Zervoudis M and Lippman M, Modern Pathology, 1/1/1997
• Detection and Quantification of Aneuploidy By In situ Hybridization on Thin Section Formalin-Fixed Archival Tissues.  
  Esteban JM, Jenkins S, Zervoudis M and Lipman M, Modern Pathology, 1/1/1997
• Prospective study of ErbB-2 extracellular domain (ECD) in serum of patients undergoing breast biopsy.  
  Esteva-Lorenzo FJ, Lippman ME, Paik S, Esteban JM, and Harris LN, Proc Am Soc Oncol, 1/1/1996
• Aromatase gene expression and its exon I usage in human breast tumors. Detection of aromatase messenger RNA by reverse transcription-polymerase chain reaction.  
  Zhou C, Zhou D, Esteban JM, Murai J, Siiteri PK, Wilczynski S, Chen S, J. Steroid Biochem. Molec. Biol., 1/1/1996
• Modulation of B16 melanoma growth and metastasis by anti-transforming growth factor beta antibody and interleukin-2.  
  Wojtowicz-Praga S, Verma U, Wakefield L, Hartmann D, Esteban JM and Mazumder A, J. Immunotherapy Emphasis Tumor Immunol, 1/1/1996
• Pseudotumoral meningeal lesion resembling meningioma.  
  Filie A., Esteban, JM, Amer Soc Clin Pathol, 1/1/1996
• Endothelial area as a prognostic indicator in invasive breast carcinoma.  
  Simpson JF, Ahn C, Battifora H and Esteban JM, Cancer, 1/1/1996
• Breast tumor xenograft targeting and therapy studies using radiolabeled chimeric monoclonal antibody T84.66.  
  Esteban JM, Current Advances in Cancer Research, 5/1/1995
• pS2 expression predicts response to hormonal therapy in breast cancer.  
  Esteban JM, Ahn C, Modern Pathology, 1/1/1995
• Skin biopsy in allogeneic and autologous bone marrow transplant patients: A histologic and immunohistochemical study with review of the literature.  
  Esteban JM and Somlo G, Modern Pathology, 1/1/1995
• Gamma-interferon administration after 90Yttrium radiolabeled antibody therapy: Survival and hematopoietic toxicity studies.  
  Thomas GE, Esteban JM, Raubitschek A. and Wong JYC, International J of Radiation Oncology Biology and Physics, 1/1/1995
• Therapy of breast cancer xenografts with Anti-CEA monoclonal antibody T84.66.  
  Esteban JM, Felder B, Wong JYC, Raubitschek A, and Shively J, International Journal of Oncology. Oncology Reports., 1/1/1995
• Initial experience evaluating 90Y radiolabeled anti-CEA chimeric T84.66 in phase I radioimmuntherapy trial.  
  Wong JYC, Williams LE, Yamauchi DM, Odom-Mayron T, Esteban JM, Neumaier M, Wu AM, Johnson DK, Primus FJ, Shively JE, Raubitschek AA, Cancer Research, 1/1/1995
• Breast tumor xenograft targeting and therapy studies using radiolabeled chimeric anti-CEA monoclonal antibody T84.66.  
  Esteban JM, Current Advances in Cancer Research, 1/1/1995
• Modulation of proliferation and tumorigenic potential of cervical carcinoma cells by the expression of sense and antisense p53.  
  Velasco JA, Stevens CW, Esteban JM, Ruthsatz MKJ, Ramsamooj P, Dritschilo A, Notario V, International Journal of Oncology, 1/1/1995
• Changes in cell cycling and cytokine levels are responsible for the radioprotective effects of 5-FU.  
  Hegyi EL, Esteban JM, Yan X, Wong J. and Raubitschek A, Blood, 1/1/1994
• Join now to see all

Books/Book Chapters

• Principles and Practice of Surgical and Cytopathology. 
  Chapter: Pleura, Pericardium and Peritoneum. 
  Sheibani K and Esteban JMEditors: Silverberg S, DeLellis RA, Frable WJ.Churchill Livingstone, New YorkEdition Thir,1997
• Radiation Research: A Twentieth Century Perspective. Volume II. 
  Chapter: Strategies to improve the efficacy of radioimmunotherapy: Radiobiologic and dosimetric considerations. 
  Page 647 - 652Wong JYC, Y X, Buras RR, Khun JA, Williams LE, Demidecki AJ, Esteban JM, Beatty JDEditors: Dewey, Edington,Fry, Hall and Whitmore.Academic Press, Inc.1992
• Fith International Radiopharmaceutical Dosimetry Symposium, Proceedings of Oak Ridge Tennessee Conference May 7-10, 1991 
  Chapter: Strategies to improve the efficacy of radioimmunotherapy: Radiobiologic effects. 
  Wong JYC, Buras RR, Khun JA, Yan X, Williams LE, Demidecki AJ, Esteban JM, Beatty JDEditors: Watson EE, Schlafke-Stelson, AT.US Department of Energy, Oak Ridge, TN1992

Abstracts/Posters

• Inflammatory myofibroblastic tumors of bladder: A clinico-pathologic study, including a subst associated with high grade carcinomas.
  E Montgomery, DD Shuster, A Bukhart, JM Eesteban, et al., Modern Pathology, 1/1/2006
• Reproducibility of quantitative gene expression analysis by a new RT-PCR assay using fixed-paraffin embedded tissues: A molecular tomographic scanning study.
  M Cronin, D Watson, M-L Liu, M Pho, JM Esteban, R Baehner, J Baker, S Shak., Modern Pathology, 1/1/2003
• Gene expression profiling of fixed-paraffin embedded tumor specimens using a 192 gene panel RT-PCR assay.
  M Kiefer, J Stephans, M-L Liu, A Nguyen, J Jeong, M Cronin, JM Esteban, AACR Oncogenomic, Phoenix, AZ, 1/1/2003
• Tumor gene expression and prognosis in breast cancer: Multi-gene RT-PCR assay of paraffin-embedded tissue.
  JM Esteban, J Baker, M Cronin, M-L Liu, MG Llamas, MG Walker, R Mena, S Shak, Oral Presentation, ASCO, Chicago, IL, 1/1/2003
• Gene expression profiling of fixed-paraffin embedded tissues: test of robustness of the technology.
  M Kiefer, J Stephans, s Abulaban, S shodhan, C Alexander, JM Esteban, Oral Presentation, ASCO, Florida, 1/1/2002
• Detection and Quantification of Aneuploidy by in situ Hybridization on Thin Section, Formalin-Fixed Tissues.
  Esteban JM, Jenkins S, Zervoudis M and Lipmann M, Modern Pathology, 1/1/1997
• Aneuploidy of Mammary Intraductal Carcinomas Detected On Tissue Sections By Non-Fluorescent In Situ Hybridization.
  Juarez D, Jenkins S, Zervoudis M and. Esteban JM, Modern Pathology, 1/1/1997
• Prospective study of ErbB-2 extracellular domain (ECD) in serum of patients undergoing breast biopsy.
  Esteva-Lorenzo F, Lippman ME, Esteban, JM, Paik S, Harris N, ASCO Meeting, 1/1/1996
• Detection And Quantification Of Aneuploidy By In situ Hybridization On Thin Section Formalin-Fixed Archival Tissues.
  Esteban JM, Jenkins S, Zervoudis M and Lipmann M, Histochemical Society 47th Annual Meeting, Washington, DC, 1/1/1996
• pS2 expression predicts response to hormonal therapy in breast cancer.
  Esteban JM, Ahn C, Chu D, Felder B,and Chen S, Modern Pathology, 1/1/1995
• Pre-clinical and clinical evaluation of an anti-CEA chimeric monoclonal antibody (cT84.66) for Radioimmunotherapy of cancer.
  Wong JYC, Thomas EG, Yamauchi D, Williams LE, Odom-Maryon T, Esteban JM, Neumaier M. et al., J Immunotherapy, 1/1/1994
• A pre-therapy imaging trial of an indium-111 anti-CEA chimeric monoclonal antibody in patients with CEA-producing malignancies.
  Wong JYC, Thomas EG, Yamauchi D, Williams LE, Odom-MaryonT, Esteban JM Neumaier M. et al., Proceedings of the 41st Annual Meeting. J Nucl Med, 1/1/1994
• Biologic significance of quantitative estrogen receptor immunohistochemical assay by image analysis in breast cancer patients.
  Esteban JM, Ahn C, Mehta P, Battifora H, Laboratory Investigation, 1/1/1994
• Increase CD19/CD10+ precursor B cells in adults post-chemotherapy for acute leukemia.
  Lopategui J, Dyer R, Traweek ST, Vall H, Esteban JM, Modern Pathology, 1/1/1994
• CEA expression in breast cancer: applicability of radiolabeled anti-CEA monoclonal antibody T84.66 in the management of the disease.
  Esteban JM, Felder B, Wong JYC, Wilson L, Raubitschek A, Shively JE, Antibody, Immunoconjugates, and Radiopharmaceuticals, 1/1/1994
• Skin Biopsy in allogeneic and autologous bone marrow transplant patients: a histologic and immunohistochemical study.
  Somlo G, Esteban JM, Modern Pathology, 1/1/1994
• Vascular surface area as a prognostic indicator in invasive breast carcinoma.
  Simpson, JF, Ahn C, Battifora H, Esteban JM, Laboratory Investigation, 1/1/1994
• Prognostic relevance of carcinoembryonic antigen and estrogen receptor status in breast cancer patients.
  Esteban JM, Felder B, Ahn C, Simpson JF, Battifora H, Shively JE, Laboratory Investigation, 1/1/1994
• Changes in cell cycling and of cytokine levels are responsible for the radioprotective effect of 5-FU.
  Hegyi E, Liu M, Esteban JM, Yan X, Wong J Raubitschek A, Blood, 1/1/1993
• Hematopoietic protective effect of gamma-interferon in mice treated with high dose Y-90-anti-CEA monoclonal antibody.
  Thomas, GE, Esteban, JM, Wong JYC, Antibody, Immunoconjugates, and Radiopharmaceuticals; Fourth Conference of Radioimmunoimaging and Radioimmunotherapy of Cancer, Princeton, NJ, 9/1/1992
• Effects of recombinant human gamma-interferon on carcinoembryonic antigen expression of human colon cancer cells.
  Yan X, Wong JYC, Esteban JM, Kuhn JA, Beatty BG, Beatty JD, Shively JE, Journal of Immunotherapy, 1/1/1992
• Improvements on the quantification of estrogen and progesterone receptors on paraffin-embedded tumors by image analysis.
  Esteban JM, Kandalaft P, Battifora H, Maryon T, Mehta P, Bacus S, Modern Pathology, 1/1/1992
• Immunohistologic characterization of gold types 1-5 anti-CEA monoclonal antibodies in colon cancer.
  Paxton R, Esteban JM, Battifora H, Mehta P, Shively J, Modern Pathology, 1/1/1992
• Detection of introtumoral aromatase in breast carcinomas: Correlation with ER and various clinico pathologic parameters.
  Esteban JM, Chen S, Hall P, Shively J, Modern Pathology, 1/1/1992
• The effects of 5-FU in RIT bone marrow toxicity in vivo.
  Thomas GE, Esteban JM, Wong JYC, Antibody, Immunoconjugates, and Radiopharmaceuticals, 1/1/1992
• Join now to see all

Lectures

• "New Prognostic Multi-Gene Test for Breast Cancer Patients". 
  Oncology Seminars. San Diego, CA - 2/1/2004
• "Prognostic Markers of Breast Cancer: What is new?". 
  Noon Seminars. Providence Hospital. Burbank, CA - 4/1/2001
• "Prognostic Markers of Breast Cancer". 
  Noon Seminars. Holy Cross Hospital. Sherman Oaks, CA - 6/1/2000
• "Prognostic and Predictive Factor of Breast Cancer: Molecular Markers". 
  California Society of Pathology.Palm Springs, CA - 5/1/1999
• "Immunochemical Approaches to Assessing Intratumoral Aromatase" 
  International Aromatase Workshop. Winterthur, Switzerland - 7/1/1997
• "Prognostic Indicators in Breast Carcinoma". 
  9th Annual Symposium Minnesota Medical Association. Minneapolis, MN - 4/1/1996
• "Methods of Evaluating Estrogen and Progesterone Receptor Expression in Breast Carcinoma". 
  Minneapolis, MN - 4/1/1996
• "Intraductal carcinoma, Atypical Intraductal Hyperplasia and Early Invasive cancer of the Breast: Differential Diagnosis and Prognostic Factors". 
  XVI Meeting of N.W. Association of Pathologists. Guaymas, Sonora, Mexico - 11/1/1995
• "Current Modern Techniques of Diagnosis and Prognosis of Breast Cancer". 
  XX LatinAmerican Congress of Pathology. Santiago de Chile, Chile - 10/1/1995
• "Prognostic factors in Cancer". (Invited Speaker) 
  Cambridge Healthtech Institute, Arlington, VA - 6/1/1995
• Diagnostic and Research Potential of Image Analysis. 
  NYU Medical Center, Seminar and Workshop. New York City - 1/1/1995
• Invited Speaker: Ninth International Conference on Monoclonal Antibody Immunoconjugates for Cancer 
  San Diego, CA - 3/1/1994
• Quantitative Pathology in Chemoprevention Trials: Standardization and Quality Control of Surrogate Endpoint Biomarker Assays for Colon, Breast and Prostate. 
  National Cancer Institutes: San Diego, CA - 2/1/1994
• Carcinoembryonic Antigen in Breast Cancer: Diagnostic and Therapeutic Applications of anti-CEA antibodies. For Breast Cancer. 
  USC. Los Angeles, CA - 2/1/1994
• Flow Cytometry vs. Image Analysis. 
  XIX American Congress of Pathology. Mexico City - 9/1/1993
• Impact of DNA Ploidy and Cell Cycle Analysis of Human Neoplasms in Oncology. 
  XIX Congress of the Spanish Academy of Pathology. Anual Meeting. Canary Islands, Spain - 5/1/1993
• Flow Cytometry Course: DNA Ploidy and Cell Cycle Analysis of Human Neoplasias. 
  XIX Cogress of the International Academy of Pathology. Madrid, Spain - 10/1/1992
• Clinical Applications of Flow Cytometry. 
  XVIII Latin American Congress of Pathology. Buenos Aires, Argentina - 10/1/1991
• Advances in the Applications of Monoclonal Antibodies in Clinical Oncology. 
  Ninth International Hammersmith Conference. Porto-Carras, Greece - 5/1/1991
• New Techniques in Diagnosis and Prognosis of Malignant Tumors. (Co-Director, Long Course) 
  USCAP Anual Meeting. Caracas, Venezuela - 4/1/1991
• Flow Cytometry Course. 
  XVIII Congress of the International Academy of Pathology. Buenos Aires, Argentina - 9/1/1990
• Clinical Flow Cytometry. 
  Grand Rounds, Eisenhower Med. Cnt. Palm Springs, CA - 2/1/1990
• Clinical Application of Flow Cytometry. 
  California - 3/1/1989
• Radioimmunoscintigraphy International Work Group 
  National Institutes of Health, Bethesda, MD - 2/1/1988
• In vivo Detection of Colo-rectal Carcinoma with Iodine Labeled B72.3 Monoclonal Antibody. (Invited Speaker) 
  UCLA School of Medicine, Los Angeles, CA - 3/1/1986
• Join now to see all

Other

• Aplicaciones Diagnostico-terapeuticas de los Anticuerpos Monoclonales Marcados. Doctoral Thesis. 
  Esteban JM, School of Medicine, University of Salamanca
  Salamanca, Spain - 1/1/1990